Democrats seize issue of stem-cell research

• Article
• Comments ()
• Click-2-Listen
• Videos

By

The political consequences of this week's wrangling over federal funding for stem-cell research won't be known until November, but Democrats say the issue illustrates why they deserve a congressional majority.

Sen. Jim Talent, Missouri Republican, is an example of how stem-cell policy could shape the fall elections. The first-term senator opposed a Senate-passed measure for additional federal funding of embryonic-stem-cell research.

He is locked in a tight race for re-election with state Auditor Claire McCaskill, a Democrat who supported the measure.

Mrs. McCaskill criticizes the incumbent senator and President Bush, who vetoed the bill, for blocking what she said amounted to hope for millions of families with sick children. Democrats adopted a similar refrain and said they will use the issue to generate support at the polls.

The House passed the stem-cell bill, but on Wednesday fell 55 votes short of the 290 needed to override Mr. Bush's veto, his first since taking office in 2001.

"When we have Democratic majorities in the House and Senate, you can bet we'll pass this legislation again," Sen. Hillary Rodham Clinton, New York Democrat, said in a letter to supporters yesterday.

House Minority Leader Nancy Pelosi, California Democrat, said, "Democrats will not give up this fight. Politically, I think 75 percent of the American people support stem-cell research. I think many of them will express themselves at the polls."

Complicating the election issue for Mr. Talent is a Missouri ballot issue, the Stem Cell Research and Cures Initiative.

Gov. Matt Blunt, a Republican, supports the initiative, as does former U.S. Sen. John C. Danforth, a pro-life Republican who is co-chairman of the ballot effort.

Missouri Democrats have endorsed the measure, but state Republicans are neutral, calling embryonic-stem-cell research a "very personal issue" that has divided their party.